| 000 | 01783 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514043415.0 | ||
| 264 | 0 | _c20021204 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a1352-0504 | ||
| 024 | 7 |
_a10.1046/j.1365-2893.2002.00378.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLurie, Y | |
| 245 | 0 | 0 |
_aA multicentre, randomized study to evaluate the safety and efficacy of histamine dihydrochloride and interferon-alpha-2b for the treatment of chronic hepatitis C. _h[electronic resource] |
| 260 |
_bJournal of viral hepatitis _cSep 2002 |
||
| 300 |
_a346-53 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 |
_aHistamine _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aNevens, F | |
| 700 | 1 | _aAprosina, Z G | |
| 700 | 1 | _aFedorova, T A | |
| 700 | 1 | _aKalinin, A V | |
| 700 | 1 | _aKlimova, E A | |
| 700 | 1 | _aIlan, Y | |
| 700 | 1 | _aMaevskaya, M V | |
| 700 | 1 | _aWarnes, T W | |
| 700 | 1 | _aYuschuk, N D | |
| 700 | 1 | _aHellstrand, K | |
| 700 | 1 | _aGehlsen, K R | |
| 773 | 0 |
_tJournal of viral hepatitis _gvol. 9 _gno. 5 _gp. 346-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2893.2002.00378.x _zAvailable from publisher's website |
| 999 |
_c12105587 _d12105587 |
||